Comparison of Two Formulations of AZD5363 and the Effect of Food on Pharmacokinetic Exposure, Safety and Tolerability

Clinical trial NCT01895946 · COMPLETED

Trial details

NCT number: NCT01895946
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Malignancy,Safety and Tolerability,Pharmacokinetics, Pharmacodynamics,Tumour Response,

Start date: 2013-12-01
Primary completion: 2015-02-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.